NASA is set to launch Artemis II with groundbreaking AVATAR technology, using astronaut tissue samples to assess health risks in space. This innovation could revolutionize both space exploration and personalized medicine.
The CDC's proposal to split the MMR vaccine into three separate shots has raised concerns among health experts. Discover the potential implications for vaccination rates and public health.
New research reveals that low- or non-sugar-sweetened beverages might be riskier for liver health than previously thought. Experts urge consumers to reconsider their choices and stick to healthier options like water.
New research reveals that drinking just one can of fizzy drinks daily can significantly increase the risk of developing a dangerous liver condition known as MASLD, challenging common beliefs about diet beverages.
A groundbreaking study reveals a significant link between sulfur dioxide emissions from fossil fuels and the risk of developing ALS. Researchers found higher SO2 exposure in ALS patients, emphasizing the need for stricter air quality regulations.
Parents like Remy Sweeney-Garrett are frustrated as CDC delays hinder COVID-19 vaccinations for children. With winter approaching, the lack of guidance raises fears about health risks, especially for vulnerable kids.
Millions of pet owners may unknowingly jeopardize their pets' and families' health by feeding raw diets that can harbor dangerous bacteria. Learn about the risks of Salmonella, E. coli, and more.
Recent research highlights a concerning rise in liver disease linked to alcohol consumption, even at previously deemed moderate levels. Discover how these trends are reshaping public health perspectives.
In a controversial announcement, the Trump administration warns that Tylenol use during pregnancy may be linked to autism. The FDA recommends limiting its use, despite ongoing debates among medical experts and manufacturers.
In a controversial statement, President Trump links Tylenol use during pregnancy to autism development, sparking debate among medical professionals who dispute the claim. Learn more about the FDA's stance and ongoing research.
